Type 1 diabetes

Long-term outcomes of pancreatic islet transplantation alone in type 1 diabetes: a 20-year single-centre study in Italy

Lancet Diabetes EndocrinolPublished Retrospective cohort study

Authors' conclusion

This analysis of a large islet transplantation alone cohort provides valuable insights into factors influencing outcomes and highlights potential risks, supporting informed clinical decision making and the optimisation of future β-cell replacement strategies.

Study context

Population
Adults aged 18–67 years with T1D diagnosed before age 55 years with severe recurrent hypoglycaemia or glycaemic instability, receiving intraportal islet transplantation alone at IRCCS Ospedale San Raffaele, Milan, Italy (2001–2023)159 islet infusions
Participants
79 adults
Outcome
Graft survival (fasting C peptide ≥0.3 ng/mL) and insulin independence
Methodological detailssingle-centre, intention-to-treat analysis
  • Single-centre
  • Intention-to-treat analysis

Main finding

As reported in the abstract

Median graft survival

3.9 years

95% CI 1.6 to 6.2

Insulin independence

44%

35/79

Median duration of insulin independence

6 years

95% CI 2.88 to 9.08

Kaplan-Meier graft survival at 1, 5, 10, 15, 20 years

86%, 65%, 47%, 47%, 40%

Observational data: associations, not effects.

Further findings

Glycaemic control after infusion

HbA1c reduction
−10.04 mmol/mol (−13.63 to −6.46)
Daily insulin requirement decrease
−13.35 units per day (−17.04 to −9.65)

Subgroup >10 000 islet equivalents (IEQ)/kg with BAS, FK506 and Rapa

Median graft survival
9.7 years (3.1-16.0)
Insulin independence
73% (16 of 22)

Patient survival · median follow-up 13.1 years

Overall survival
92% (73 of 79)
20-year survival probability
84%

Safety

Procedural complications

Complications infrequent, mostly minor bleeding; surgical intervention required
3% (two of 79)

Immunosuppression-related adverse events and allosensitisation

Adverse events related to immunosuppressive therapy
44% (35 of 79)
Allosensitisation: baseline vs after therapy discontinuation
6% vs 42%

Original publication

Long-term outcomes of pancreatic islet transplantation alone in type 1 diabetes: a 20-year single-centre study in Italy. Lancet Diabetes Endocrinol. Published 7 February 2025. doi:10.1016/s2213-8587(24)00341-3

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.